Literature DB >> 11939741

Discrepancies in the immunophenotype of lymphoma cells in samples obtained simultaneously from different anatomic sites.

Mihaela Onciu1, Su G Berrak, L Jeffrey Medeiros, Ruth L Katz, Yang O Huh.   

Abstract

Few studies have compared the immunophenotypic profiles of non-Hodgkin lymphoma (NHL) cells obtained simultaneously from different anatomic sites. In the present study, we compared flow cytometry immunophenotypic results in 64 consecutive NHL cases in which aspiration or biopsy of 2 sites was performed within 30 days to assess the potential discrepancy rate. In 14 cases (22%), discordant antigen expression was identified, including 4 (36%) of 11 cases with discordant morphologic features and 10 (19%) of 53 cases with concordant morphologic features in the 2 samples. Discrepancies involved 1 antigen in 10 patients and 2 antigens in 4 patients. Antigens most frequently discrepant included CD5 (n = 4), FMC7 (n = 3), and CD20 (n = 3). We conclude that the immunophenotype of NHL cells is generally stable, yet discrepancies can occur in a subset of patients. Differences in immunophenotype may relate to mechanisms of disease dissemination, influence of the microenvironment, or differential response to therapy.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11939741     DOI: 10.1309/urtd-7md9-u8n1-c60q

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  2 in total

1.  A CD5+ Anaplastic DLBCL with Reed-Sternberg-Like Cells: A Diagnostic Pitfall.

Authors:  Sudha Sharma; Prashant Sharma; Man Updesh Singh Sachdeva; Gaurav Prakash; Amanjit Bal; Neelam Varma
Journal:  Indian J Hematol Blood Transfus       Date:  2018-01-10       Impact factor: 0.900

2.  Overlapping morphologic and immunophenotypic profiles in small B-cell lymphoma. A report of two cases.

Authors:  Ioannis Kostopoulos; Mario Cocco; Chiara Ginanneschi; Alessandro D'Amuri; Stefano Lazzi; Alberto Fabbri; Francesco Forconi; Maria Margherita De Santi; Lorenzo Leoncini
Journal:  Virchows Arch       Date:  2006-07-18       Impact factor: 4.064

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.